Praful Agrawala

Praful Agrawala has a diverse work experience spanning over three decades in the pharmaceutical industry.

Praful is currently working as the Head of CMC at Reviva Pharmaceuticals, a position they assumed in February 2022.

Before joining Reviva Pharmaceuticals, Praful was the Executive Vice President of Pharmaceutical Technology at Frontida BioPharm, Inc. from November 2020 to November 2021. During this time, they managed small molecule contract development and played a crucial role in the senior leadership team.

From 2014 to 2019, Praful served as the Senior Vice President of Inhalation Product Development at Amneal Pharmaceuticals. In this role, they developed the company's inhalation generic product portfolio, established respiratory R&D capabilities, and played a key role in technology transfer to the company's manufacturing site in Ireland.

Prior to this, Praful was the Chief Operating Officer at PharmaSophia LLC, a joint venture between Amneal Pharmaceuticals and Oakwood Labs. Praful was responsible for overseeing the development and manufacturing of microsphere-based sustained-release injectable pharmaceuticals.

In addition, Praful has also worked as an independent consultant through their own company, Agrawala CMC Consulting LLC, providing services to small and mid-size pharmaceutical companies. Praful has been involved in various projects, including the development of a drug-device combination approved by the FDA.

Earlier in their career, Praful held leadership positions at Sanofi, Aventis Pharmaceuticals, and Schering-Plough Research Institute, where they contributed to the development of innovative therapeutics and managed CMC development and optimization processes for various drug delivery formats.

Overall, Praful Agrawala's work experience showcases their expertise in pharmaceutical development, project management, and leadership in the pharmaceutical industry.

Praful Agrawala holds a Doctor of Philosophy (PhD) degree in Pharmaceutical Sciences from the University of Cincinnati, which they obtained from 1982 to 1987. Prior to that, they completed their Bachelor of Pharmacy (B.Pharm.) degree from the Indian Institute of Technology (Banaras Hindu University) in Varanasi, from 1977 to 1981. In addition to their formal education, they have also attained a Regulatory Affairs Certificate from the Regulatory Affairs Professional Society (RAPS) in 2012.